AC Immune SA (NAS:ACIU)
$ 3.69 0 (0%) Market Cap: 365.09 Mil Enterprise Value: 164.04 Mil PE Ratio: 0 PB Ratio: 2.68 GF Score: 42/100

AC Immune SA KOL Webinar Transcript

Apr 18, 2023 / 02:30PM GMT
Release Date Price: $2.21 (+0.23%)
Operator

Good morning and welcome to the AC Immune KOL Webinar on the Early Diagnosis and Prevention of Alzheimer's Disease. (Operator Instructions) As a reminder, this call is being recorded and a replay will be made available on the AC Immune website following the conclusion of the event.

I'd now like to turn the call over to your host, Gary Waanders, Head of Investor Relations and Communications at AC Immune. Please go ahead, Gary.

Gary Waanders
AC Immune SA - Head of IR & Corporate Communications

Thanks, Tara, and welcome to everyone joining us today. We're delighted to be hosting this webinar, where we'll be hearing from two distinguished guest speakers.

Before I begin, I would like to remind everyone that today's presentation will contain some forward-looking statements and point out our disclaimer as shown on this slide.

So we'll begin today's webinar with a brief overview of AC Immune's strategy and pipeline from CEO, Dr. Andrea Pfeifer. We will then hear from Dr. Kaj Blennow from the University of Gothenburg in Sweden, who will

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot